Abstract Purpose of Review To discuss the prevailing racial and ethnic disparities in heart
failure (HF) care by identifying barriers to equitable care and proposing solutions for …

Racial and ethnic minorities have the highest incidence, prevalence, and hospitalization
rates from heart failure. In spite of improved therapies and overall survival, the mortality …

Guideline-directed medical therapies and guideline-directed nonpharmacological therapies
improve quality of life and survival in patients with heart failure (HF), but eligible patients …

The treatment of heart failure (HF) with reduced ejection fraction (HFrEF) has substantially
developed over the past decades. More than ever before, the application of appropriate …

Purpose: Heart failure (HF) disproportionately impacts African Americans. We evaluated
existing quality improvement (QI) initiatives and patient and provider perceptions of barriers …

Heart failure (HF) remains a condition associated with high morbidity, mortality, and
associated costs. Although the number of medical and device-based therapies available to …

Black patients develop heart failure at younger ages and have worse outcomes such as
higher mortality rates compared to other racial and ethnic groups in the United States …

The last several decades have witnessed great strides forward in heart failure (HF)
therapeutics; however, HF remains one of the leading causes of morbidity and mortality in …

Over the last several decades, we have witnessed great strides forward in heart-failure
therapeutics. While the usual challenges and targets for new interventions persist …

Although care of patients with heart failure (HF) has improved in the past decade, important
disparities in HF outcomes persist based on race/ethnicity. Age-adjusted HF-related …